Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]

Background: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that is produced at varying levels in patients with coronavirus disease 2019 (COVID-19). The neutrophil–lymphocyte ratio (NLR) is one of the new inflammatory markers of COVID-19. This study aimed to evaluate the differences in IL-6 leve...

Full description

Bibliographic Details
Main Authors: Andi Nilawati Usman, Umi Solekhah Intansari, Budi Mulyono, Gita Vita Soraya, Tenri Esa, Budu Budu
Format: Article
Language:English
Published: F1000 Research Ltd 2023-09-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/12-1189/v1
_version_ 1797392294552272896
author Andi Nilawati Usman
Umi Solekhah Intansari
Budi Mulyono
Gita Vita Soraya
Tenri Esa
Budu Budu
author_facet Andi Nilawati Usman
Umi Solekhah Intansari
Budi Mulyono
Gita Vita Soraya
Tenri Esa
Budu Budu
author_sort Andi Nilawati Usman
collection DOAJ
description Background: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that is produced at varying levels in patients with coronavirus disease 2019 (COVID-19). The neutrophil–lymphocyte ratio (NLR) is one of the new inflammatory markers of COVID-19. This study aimed to evaluate the differences in IL-6 level and the NLR in mild and severe COVID-19 and assess their correlation with COVID-19 severity and the correlation of IL-6 and NLR in COVID-19. Methods: A total of 91 patients with COVID-19 were divided into mild (n = 57) and severe (n = 34) COVID-19 groups. IL-6 levels were measured using the electrochemiluminescence immunoassay method on Roche Cobas e411. The NLR was the ratio of the total neutrophil and lymphocyte counts from complete haematology on the Sysmex XS-800i. Data were analysed using the Kolmogorov–Smirnov, Mann–Whitney, receiver operating characteristic curve, chi-square and Spearman correlation tests. The statistical test was significant at p <0.05. Results: Serum IL-6 levels and NLR significantly differed in mild and severe COVID-19. The median (min–max) IL-6 levels for mild and severe COVID-19 were 3.59 (1.50–638.30) pg/mL and 28.82 (5.52–926.30) pg/mL, respectively (p <0.001). The median (min–max) NLR in mild and moderate COVID-19 was 2.18 (0.69–15.58) and 8.13 (2.24–30.90), respectively (p <0.001). The obtained cut-off values for IL-6 and NLR were >6.99 pg/mL and >4.18, with odds ratios of 29.29 and 26.19, respectively. A positive correlation was found between IL-6 and NLR and COVID-19 severity (r = 0.612; p <0.001). Conclusions: The results indicated that serum IL-6 levels and NLR are higher in severe COVID-19 than in mild COVID-19. Patients with IL-6 levels >6.99 pg/mL and NLR >4.18 are 29 and 26 times more likely to suffer from severe COVID-19, respectively. Serum IL-6 levels and NLR are strongly correlated with COVID-19 severity. Serum IL-6 levels correlate with NLR in COVID-19.
first_indexed 2024-03-08T23:45:10Z
format Article
id doaj.art-eb82b0d40c5449d9a7664dc40177b289
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-03-08T23:45:10Z
publishDate 2023-09-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-eb82b0d40c5449d9a7664dc40177b2892023-12-14T01:01:43ZengF1000 Research LtdF1000Research2046-14022023-09-0112145062Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]Andi Nilawati Usman0https://orcid.org/0000-0002-1136-1704Umi Solekhah Intansari1Budi Mulyono2Gita Vita Soraya3Tenri Esa4https://orcid.org/0000-0002-8373-6755Budu Budu5Graduate School, Hasanuddin University, Makassar, South Sulawesi, 90245, IndonesiaFaculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Special Region of Yogyakarta, IndonesiaFaculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Special Region of Yogyakarta, IndonesiaGraduate School, Hasanuddin University, Makassar, South Sulawesi, 90245, IndonesiaFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90245, IndonesiaFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90245, IndonesiaBackground: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that is produced at varying levels in patients with coronavirus disease 2019 (COVID-19). The neutrophil–lymphocyte ratio (NLR) is one of the new inflammatory markers of COVID-19. This study aimed to evaluate the differences in IL-6 level and the NLR in mild and severe COVID-19 and assess their correlation with COVID-19 severity and the correlation of IL-6 and NLR in COVID-19. Methods: A total of 91 patients with COVID-19 were divided into mild (n = 57) and severe (n = 34) COVID-19 groups. IL-6 levels were measured using the electrochemiluminescence immunoassay method on Roche Cobas e411. The NLR was the ratio of the total neutrophil and lymphocyte counts from complete haematology on the Sysmex XS-800i. Data were analysed using the Kolmogorov–Smirnov, Mann–Whitney, receiver operating characteristic curve, chi-square and Spearman correlation tests. The statistical test was significant at p <0.05. Results: Serum IL-6 levels and NLR significantly differed in mild and severe COVID-19. The median (min–max) IL-6 levels for mild and severe COVID-19 were 3.59 (1.50–638.30) pg/mL and 28.82 (5.52–926.30) pg/mL, respectively (p <0.001). The median (min–max) NLR in mild and moderate COVID-19 was 2.18 (0.69–15.58) and 8.13 (2.24–30.90), respectively (p <0.001). The obtained cut-off values for IL-6 and NLR were >6.99 pg/mL and >4.18, with odds ratios of 29.29 and 26.19, respectively. A positive correlation was found between IL-6 and NLR and COVID-19 severity (r = 0.612; p <0.001). Conclusions: The results indicated that serum IL-6 levels and NLR are higher in severe COVID-19 than in mild COVID-19. Patients with IL-6 levels >6.99 pg/mL and NLR >4.18 are 29 and 26 times more likely to suffer from severe COVID-19, respectively. Serum IL-6 levels and NLR are strongly correlated with COVID-19 severity. Serum IL-6 levels correlate with NLR in COVID-19.https://f1000research.com/articles/12-1189/v1Coronavirus disease-19 COVID-19 Interleukin-6 IL-6 neutrophil–lymphocyte ratio serum leveleng
spellingShingle Andi Nilawati Usman
Umi Solekhah Intansari
Budi Mulyono
Gita Vita Soraya
Tenri Esa
Budu Budu
Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
F1000Research
Coronavirus disease-19
COVID-19
Interleukin-6
IL-6
neutrophil–lymphocyte ratio
serum level
eng
title Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
title_full Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
title_fullStr Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
title_full_unstemmed Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
title_short Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations, 1 not approved]
title_sort correlation of serum interleukin 6 levels and neutrophil lymphocyte ratio in the severity of covid 19 version 1 peer review 1 approved 2 approved with reservations 1 not approved
topic Coronavirus disease-19
COVID-19
Interleukin-6
IL-6
neutrophil–lymphocyte ratio
serum level
eng
url https://f1000research.com/articles/12-1189/v1
work_keys_str_mv AT andinilawatiusman correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved
AT umisolekhahintansari correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved
AT budimulyono correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved
AT gitavitasoraya correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved
AT tenriesa correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved
AT budubudu correlationofseruminterleukin6levelsandneutrophillymphocyteratiointheseverityofcovid19version1peerreview1approved2approvedwithreservations1notapproved